Low‐dose prophylaxis for children with haemophilia in a resource‐limited setting in south India—A clinical audit report

dosing scheme; guiding dose frequency in older patients switching from on demand to prophylaxis; and assessing the clinical efficacy of new molecules. The scoring method we propose is a relatively simple approach to determining bleeding phenotype. A potential next step might be to test the usefulness of our scoring system prospectively in welldefined cohorts. Until fully validated, this scoring system should be applied selectively to avoid the consequences of bleeding. Possible situations might include a PWH desiring a lower frequency of injections or one who wants to try newer agents, such as extended halflife products.